11/20/2024
5:36 PM | Skycrest Holdings, LLC (Reporting)
Organicell Regenerative Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
7:30 AM | Organicell Regenerative Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
7:45 AM | Organicell Regenerative Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
7:30 AM | Organicell Regenerative Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
5:01 AM | Organicell Regenerative Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
7:52 PM | Skycrest Holdings, LLC (Reporting)
Organicell Regenerative Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
10:13 AM | Kompothecras Gary (Filed by)
Organicell Regenerative Medicine (Subject)
| Form SC 13G | |
08/07/2024
3:49 PM | Organicell Regenerative Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
6:00 PM | Grey Wendy (Reporting)
Greyt Ventures, LLC (Reporting)
Organicell Regenerative Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
4:20 PM | BOTHWELL IAN T (Reporting)
Organicell Regenerative Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
4:20 PM | Bretz Charles Luther (Reporting)
Organicell Regenerative Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
4:20 PM | GLAUSER STEVEN JERRY (Reporting)
Organicell Regenerative Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
4:21 PM | Shapiro George Craig (Reporting)
Organicell Regenerative Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
4:21 PM | Skycrest Holdings, LLC (Reporting)
Organicell Regenerative Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
4:22 PM | Stearn Leathem S (Reporting)
Organicell Regenerative Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:10 PM | Bretz Charles Luther (Reporting)
Organicell Regenerative Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:10 PM | GLAUSER STEVEN JERRY (Reporting)
Organicell Regenerative Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:11 PM | Stearn Leathem S (Reporting)
Organicell Regenerative Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:11 PM | Singh Gurvinder Pal (Reporting)
Organicell Regenerative Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
3:36 PM | Organicell Regenerative Medicine (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/20/2023
5:30 AM | Organicell Regenerative Medicine (Filer)
| Form DEF 14C | |
12/12/2023
3:15 PM | Organicell Regenerative Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2023
4:00 PM | Organicell Regenerative Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
